KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.22.

  • Pfizer's Asset Utilization Ratio fell 414.72% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 414.72%. This contributed to the annual value of 0.29 for FY2024, which is 3340.09% down from last year.
  • As of Q3 2025, Pfizer's Asset Utilization Ratio stood at 0.22, which was down 414.72% from 0.22 recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Asset Utilization Ratio peaked at 0.67 during Q4 2022, and registered a low of 0.11 during Q4 2023.
  • Over the past 5 years, Pfizer's median Asset Utilization Ratio value was 0.22 (recorded in 2025), while the average stood at 0.31.
  • Per our database at Business Quant, Pfizer's Asset Utilization Ratio crashed by 8368.08% in 2023 and then skyrocketed by 10630.81% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Asset Utilization Ratio stood at 0.53 in 2021, then grew by 24.52% to 0.67 in 2022, then plummeted by 83.65% to 0.11 in 2023, then soared by 94.8% to 0.21 in 2024, then increased by 2.37% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.22 for Q2 2025, and 0.21 during Q1 2025.